Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis.

作者: Brahmajee K. Nallamothu , Kaveh G. Shojania , Sanjay Saint , Timothy P. Hofer , H. David Humes

DOI: 10.1016/J.AMJMED.2004.06.046

关键词:

摘要: PURPOSE: Clinical trials evaluating acetylcysteine for the prevention of contrast-related nephropathy have reported mixed results. Although previous meta-analyses have concluded …

参考文章(48)
Anne Whitehead, Meta-Analysis Of Controlled Clinical Trials Statistics in Practice. ,(2002) , 10.1002/0470854200
H. D. Humes, D. A. Hunt, M. D. White, Direct toxic effect of the radiocontrast agent diatrizoate on renal proximal tubule cells American Journal of Physiology-renal Physiology. ,vol. 252, ,(1987) , 10.1152/AJPRENAL.1987.252.2.F246
G Helft, F Beygui, J P Metzger, J P Batisse, C Le Feuvre, K H Le Quan Sang, R El Mahmoud, [Absence of nephro-protective effect of acetylcysteine in patients with chronic renal failure investigated by coronary angiography]. Archives Des Maladies Du Coeur Et Des Vaisseaux. ,vol. 96, pp. 1157- 1161 ,(2003)
R Collins, R Peto, M Flather, S Parish, P Sleight, M Conway, A Pipilis, C Baigent, D Barnett, JP Boissel, A Budaj, J Cairns, L Ceremuzynski, AF Cohen, Gui De Backer, R Diaz, F Dienstl, P Dove, MG Franzosi, M Genoni, DA Halon, J Heikkila, C Hennekens, J Horgan, D Hunt, R Kala, N Karatzas, A Keech, M Keltai, J Kjekshus, M Kornitzer, R Koster, P Landless, P Lechleitner, A Leizorovicz, BS Lewis, L Lundkvist, S Macmahon, A Maggioni, R Malacrida, T Meyer, T Moccetti, D Ocallaghan, E Paolasso, LS Piegas, A Reikvam, P Ridker, T Ryan, R Schroder, R Seabragomes, JEMR Sousa, G Tognoni, A Turpie, V Valentin, J Varigos, H White, L Wilhelmsen, K Woods, S Yusuf, A Piombo, LA Guzman, DC Montenegro, G Irusta, RA Schneider, C Cuneo, BH Chamorro, GE Espinosa, M Moreno, MM Rios, R Doll, K Fox, D Julian, P Meier, E Sandoya, JE Perez, None, ISIS-4 - A randomised factorial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patient with suspected acute myocardial-infarction. The Lancet. ,vol. 345, pp. 669- 685 ,(1995)
Joëlle M. KEFER, Claude E. HANET, Sabine BOITTE, Léon WILMOTTE, Martine DE KOCK, Acetylcysteine, coronary procedure and prevention of contrast-induced worsening of renal function: which benefit for which patient? Acta Cardiologica. ,vol. 58, pp. 555- 560 ,(2003) , 10.2143/AC.58.6.2005321
Erik von Elm, Michael C Costanza, Bernhard Walder, Martin R Tramèr, More insight into the fate of biomedical meeting abstracts: a systematic review. BMC Medical Research Methodology. ,vol. 3, pp. 12- 12 ,(2003) , 10.1186/1471-2288-3-12
Jay Kay, Wing Hing Chow, Tak Mao Chan, Sing Kai Lo, On Hing Kwok, Alex Yip, Katherine Fan, Chi Hang Lee, Wai Fai Lam, Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA. ,vol. 289, pp. 553- 558 ,(2003) , 10.1001/JAMA.289.5.553
Neesh Pannu, Braden Manns, Helen Lee, Marcello Tonelli, Systematic review of the impact of N-acetylcysteine on contrast nephropathy Kidney International. ,vol. 65, pp. 1366- 1374 ,(2004) , 10.1111/J.1523-1755.2004.00516.X
Rosario V Freeman, Michael O’Donnell, David Share, William L Meengs, Eva Kline-Rogers, Vivian L Clark, Anthony C DeFranco, Kim A Eagle, John G McGinnity, Kirit Patel, Ann Maxwell-Eward, Diane Bondie, Mauro Moscucci, Blue Cross Blue Shield of Michigan Cardiovascular Consortium, Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. American Journal of Cardiology. ,vol. 90, pp. 1068- 1073 ,(2002) , 10.1016/S0002-9149(02)02771-6